These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 16406763

  • 1. Pharmacological therapy of Paget's and other metabolic bone diseases.
    Hosking D.
    Bone; 2006 Feb; 38(2 Suppl 2):S3-7. PubMed ID: 16406763
    [Abstract] [Full Text] [Related]

  • 2. Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate.
    Hosking D, Lyles K, Brown JP, Fraser WD, Miller P, Curiel MD, Devogelaer JP, Hooper M, Su G, Zelenakas K, Pak J, Fashola T, Saidi Y, Eriksen EF, Reid IR.
    J Bone Miner Res; 2007 Jan; 22(1):142-8. PubMed ID: 17032148
    [Abstract] [Full Text] [Related]

  • 3. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
    Abelson A.
    Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
    [Abstract] [Full Text] [Related]

  • 4. Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.
    Reid IR, Miller P, Lyles K, Fraser W, Brown JP, Saidi Y, Mesenbrink P, Su G, Pak J, Zelenakas K, Luchi M, Richardson P, Hosking D.
    N Engl J Med; 2005 Sep 01; 353(9):898-908. PubMed ID: 16135834
    [Abstract] [Full Text] [Related]

  • 5. Is a single infusion of zoledronic acid more effective than oral risedronate for the treatment of patients with Paget's disease?
    Krane SM.
    Nat Clin Pract Rheumatol; 2006 Apr 01; 2(4):186-7. PubMed ID: 16932682
    [No Abstract] [Full Text] [Related]

  • 6. Medical management of Paget's disease of bone: indications for treatment and review of current therapies.
    Siris ES, Lyles KW, Singer FR, Meunier PJ.
    J Bone Miner Res; 2006 Dec 01; 21 Suppl 2():P94-8. PubMed ID: 17229018
    [Abstract] [Full Text] [Related]

  • 7. Management of Paget's disease of bone.
    Langston AL, Ralston SH.
    Rheumatology (Oxford); 2004 Aug 01; 43(8):955-9. PubMed ID: 15187244
    [Abstract] [Full Text] [Related]

  • 8. Case report of implant placement in a patient with Paget's disease on bisphosphonate therapy.
    Pirih FQ, Zablotsky M, Cordell K, McCauley LK.
    J Mich Dent Assoc; 2009 May 01; 91(5):38-43. PubMed ID: 19537656
    [Abstract] [Full Text] [Related]

  • 9. Current treatment approaches for Paget's Disease of Bone.
    Brandi ML.
    Discov Med; 2010 Sep 01; 10(52):209-12. PubMed ID: 20875342
    [Abstract] [Full Text] [Related]

  • 10. Risedronate: clinical usage.
    Chapurlat RD, Delmas PD.
    Int J Clin Pract; 2001 May 01; 55(4):275-8. PubMed ID: 11406915
    [Abstract] [Full Text] [Related]

  • 11. Zoledronic acid for Paget's disease of bone.
    Maricic M.
    Drugs Today (Barc); 2007 Dec 01; 43(12):879-85. PubMed ID: 18174973
    [Abstract] [Full Text] [Related]

  • 12. Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone.
    Whitson HE, Lobaugh B, Lyles KW.
    Bone; 2006 Oct 01; 39(4):954-8. PubMed ID: 16769264
    [Abstract] [Full Text] [Related]

  • 13. Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates.
    Rendina D, Mossetti G, Viceconti R, Sorrentino M, Nunziata V.
    Calcif Tissue Int; 2004 Sep 01; 75(3):189-96. PubMed ID: 15148558
    [Abstract] [Full Text] [Related]

  • 14. Treatment of Paget's disease of bone: a survey of clinical practice in Australia.
    Walsh JP, Attewell R, Stuckey BG, Hooper MJ, Wark JD, Fletcher S, Ferrari V, Eisman JA.
    Bone; 2008 Jun 01; 42(6):1219-25. PubMed ID: 18353737
    [Abstract] [Full Text] [Related]

  • 15. Paget disease of bone - an update.
    Britton C, Walsh J.
    Aust Fam Physician; 2012 Mar 01; 41(3):100-3. PubMed ID: 22396921
    [Abstract] [Full Text] [Related]

  • 16. Paget's disease of bone: experience from a centre in southern India.
    Anjali, Thomas N, Rajaratnam S, Shanthly N, Oommen R, Seshadri MS.
    J Assoc Physicians India; 2006 Jul 01; 54():525-9. PubMed ID: 17089899
    [Abstract] [Full Text] [Related]

  • 17. Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone.
    Martini G, Gennari L, Merlotti D, Salvadori S, Franci MB, Campagna S, Avanzati A, De Paola V, Valleggi F, Nuti R.
    Bone; 2007 Feb 01; 40(2):457-63. PubMed ID: 16979395
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of Paget's disease of bone with zoledronic acid].
    Body JJ, Sternon J.
    Rev Med Brux; 2005 Feb 01; 26(6):513-7. PubMed ID: 16454155
    [Abstract] [Full Text] [Related]

  • 19. [Optimizing therapy in Paget disease].
    Füessl HS.
    MMW Fortschr Med; 2005 Dec 15; 147(51-52):32. PubMed ID: 16402704
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone.
    Merlotti D, Gennari L, Martini G, Valleggi F, De Paola V, Avanzati A, Nuti R.
    J Bone Miner Res; 2007 Oct 15; 22(10):1510-7. PubMed ID: 17605632
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.